Explore

Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Trendline Trendline
Cryoport Reports Strong Q1 2026 Financial Results with Revenue Growth

Cryoport Reports Strong Q1 2026 Financial Results with Revenue Growth

Cryoport Reports Strong Q1 2026 Financial Results with Revenue Growth
Trendline Trendline
Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings
Trendline Trendline
Freemelt Holding Reports 116% Increase in Q1 2026 Sales

Freemelt Holding Reports 116% Increase in Q1 2026 Sales

Freemelt Holding Reports 116% Increase in Q1 2026 Sales
Trendline Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Trendline Trendline
Cryoport Reports Strong Q1 2026 Financial Results with Increased Clinical Trials

Cryoport Reports Strong Q1 2026 Financial Results with Increased Clinical Trials

Cryoport Reports Strong Q1 2026 Financial Results with Increased Clinical Trials
Trendline Trendline
AGC Biologics Partners with Novelty Nobility to Advance Bispecific Drug Candidate for Retinal Diseases

AGC Biologics Partners with Novelty Nobility to Advance Bispecific Drug Candidate for Retinal Diseases

AGC Biologics Partners with Novelty Nobility to Advance Bispecific Drug Candidate for Retinal Diseases
Trendline Trendline
Badger Meter Faces Investor Scrutiny After Disappointing Financial Results

Badger Meter Faces Investor Scrutiny After Disappointing Financial Results

Badger Meter Faces Investor Scrutiny After Disappointing Financial Results
Trendline Trendline
Gränges Reports Strong Q1 Results Amid Currency and Cost Challenges

Gränges Reports Strong Q1 Results Amid Currency and Cost Challenges

Gränges Reports Strong Q1 Results Amid Currency and Cost Challenges